Navigation Links
Watson Full Year 2011 Net Revenue Increases 29% to $4.58 Billion;
Date:2/14/2012

ue increased 44 percent to $3.4 billion, including product sales of $3.3 billion and other revenue of $47.0 million.  

Adjusted Global Generics gross margin decreased from 49.9 percent in 2010 to 46.2 percent in 2011, due to sales of the authorized generic versions of Lipitor® and Concerta® at lower margins.  Global Brands Segment InformationThree Months EndedTwelve Months EndedDecember 31,December 31,(Unaudited; $ in millions)

2011201020112010Product sales

$
.1$
84.6$
364.9$
316.3Other revenue

20.818.776.181.5Net revenue

120.9103.3441.0397.8Operating expenses:Cost of sales

26.120.394.488.4Research and development

6.945.367.7101.5Selling and marketing

46.535.6168.6137.8Segment contribution

$
41.4$
2.1$
.3$
70.1Segment margin

34.2%2.0%25.0%17.6%Adjusted gross profit (1)

$
94.8$
83.0$
347.2$
309.4Adjusted gross margin

78.4%80.3%78.7%77.8%(1) Adjusted gross profit represents net revenue less

adjusted cost of sales and excludes amortization of

acquired intangibles. Pro forma adjustments for the

respective periods include the following: Acquisition and licensing

$
-$
-$
.6$
-Global Brands net revenue increased 17 percent to $120.9 million in the fourth quarter of 2011.  The increase in revenue was primarily the result of increased sales of Rapaflo® and Crinone® and the addition of new products including Generess® Fe.

Global Brands R&D investment decreased $38.4 million in the fourth quarter 2011 when compared to the fourth quarter 2010. The current year includes $13.1 million reduction in expense due to the revaluation of contingent liabilities, partially offset by licensing payments of $1.5 million and the prior year includes $24.9 million of additional expense associated with development milestone payments and revaluation of contingent liabilities.  Glob
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
8. Watson Completes Acquisition of Eden Biodesign
9. Watson to Present at Credit Suisse Healthcare Conference
10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
11. Watson Files FDA Application for Generic Rozerem(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013   Accuray Incorporated ... publication of study results involving hundreds of prostate ... System, the most widely used form of prostate ... 304 patients for a median of 5 years, ... that 97 percent of patients with low-risk and ...
(Date:5/21/2013)... ORLANDO, Fla. , May 21, 2013 /PRNewswire/ ... and safety results from the global Phase 3 ... protease inhibitor simeprevir (TMC435) led to sustained virologic ... (SVR12) in 79 percent of treatment-experienced genotype 1 ... disease, including all stages of liver fibrosis, when ...
(Date:5/21/2013)... , May 21, 2013 Abaxis, Inc. ... analysis systems, announced today that Martin Mulroy ... the Stifel Annual Dental & Veterinary Conference on Wednesday, ... will be held at Le Parker Meridien Hotel in ... About Abaxis Abaxis develops, manufactures, markets and ...
Breaking Medicine Technology:New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2
... Sept. 9, 2011 Valeant Pharmaceuticals International, Inc. (" Valeant ... of Afexa Life Sciences Inc. (" Afexa ") its offer ... friendly offer (the " Offer ") for all of the ... at a price of C$0.71 in cash per Common Share. ...
... YORK, Sept. 8, 2011 NeoStem, Inc. (NYSE ... "Company"), an international biopharmaceutical company with a focus ... presenting at three upcoming September conferences: the Rodman ... Commercialization Summit, and the JMP Securities Healthcare Conference. ...
Cached Medicine Technology:Valeant Pharmaceuticals Announces Mailing of Offer and Take-Over Bid Circular to Shareholders of Afexa 2Valeant Pharmaceuticals Announces Mailing of Offer and Take-Over Bid Circular to Shareholders of Afexa 3Valeant Pharmaceuticals Announces Mailing of Offer and Take-Over Bid Circular to Shareholders of Afexa 4NeoStem Announces Participation in Multiple September Conferences 2NeoStem Announces Participation in Multiple September Conferences 3
(Date:5/21/2013)... results from SOURCE XT one of the largest, ... reported today at EuroPCR 2013 show good clinical outcomes ... success for all access approaches, valve sizes and delivery ... 2688 consecutively enrolled patients (mean age 81.5 years) undergoing ... centres in 17 countries between July 2010 and October ...
(Date:5/21/2013)... Los Angeles, CA (PRWEB) May 21, 2013 ... titled “Time to Rethink the Use of Botox,” Botox ... the world since their approval in 2002 (Go to goo.gl/8iYbD). ... has become quite popular with men. The injection makes facial ... a single Botox injection last for about three months. This ...
(Date:5/21/2013)... Phoseon Technology will present their advanced ... IMI European Ink Jet Conference (June 5-6, Barcelona, ... to invest in product development to enable breakthrough capability ... curing in printing applications. Phoseon currently has a ... both air cooled and water cooled solutions to match ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 MedMar Healing ... drive to benefit Second Harvest Food Bank. Twenty-eight businesses, including ... participate in the food drive. The goal is to raise ... the economic problems facing their families in recent years. ... community and help those in need,” explains Douglas Chloupek of ...
(Date:5/21/2013)... roles two proteins, thrombospondin-1 and prosaposin, play in ... identified a five-amino acid fragment of prosaposin that ... prostate, breast and lung cancer. The findings suggest ... in a variety of cancers. , The ... Boston Children,s Hospital, Vivek Mittal, PhD, at Weill ...
Breaking Medicine News(10 mins):Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2Health News:San Jose Cannabis Club Helps Feed Hungry Children with Second Harvest Food Bank 2Health News:Changing cancer's environment to halt its spread 2Health News:Changing cancer's environment to halt its spread 3
... You Are Still Doing Only for OthersSEYMOUR, Tenn., May 1 ... to honor their mothers for all the hard work and ... family first everyday of the year, many times over themselves, ... day designed to celebrate a mother,s love and support can ...
... Boston, MAFollowing the declaration of a public health emergency due ... the Harvard Opinion Research Program at the Harvard School of ... about the outbreak, how they are responding and what they ... about the outbreak , The survey finds that nearly half ...
... Ronald McDonald House Acknowledges Decades of ... more than necessary to keep the non-profit segment ... Ronald McDonald House of Delaware is making sure ... Volunteer Recognition Wall is set to premiere this ...
... 8th Annual National Day to Prevent Teen PregnancyWASHINGTON, May 1 ... rate in the United States increased 5% between 2005 and ... Campaign to Prevent Teen and Unplanned Pregnancy will examine why ... to try to reverse the trend.The forum will take place ...
... National Osteoporosis Foundation calls on Moms to Address Bone Health ... that generations of women have passed on to their loved ... knowledge about health -- especially information about bone health and ... Gift from Mothers to Daughters as the theme for ...
... benefitSAINT PAUL, Minn., May 1 Second Harvest ... honored David Nasby, former vice president of the ... first food bank network, with its inaugural Hunger ... contributions to hunger relief."I am humbled to receive ...
Cached Medicine News:Health News:Feel Like Everyone Forgets Mother's Day Is for Mothers? 2Health News:Feel Like Everyone Forgets Mother's Day Is for Mothers? 3Health News:Survey finds nearly half of Americans concerned they or their family may get sick from swine flu 2Health News:Survey finds nearly half of Americans concerned they or their family may get sick from swine flu 3Health News:Artist Contributes to Volunteer Recognition 2Health News:Forum Explores Solutions to the Rise in the Teen Birth Rate 2Health News:Forum Explores Solutions to the Rise in the Teen Birth Rate 3Health News:Family History is Key Risk Factor in Developing Osteoporosis 2Health News:Family History is Key Risk Factor in Developing Osteoporosis 3Health News:Second Harvest Heartland Honors Hunger Hero David Nasby 2Health News:Second Harvest Heartland Honors Hunger Hero David Nasby 3
2.5x8mm Spatula Combined with 8mm Blade; in stainless steel....
0.6mm Tip x10mm Shaft, Straight Shaft, 90 Degree Hook at Tip; overall length 120mm; in Titianium....
Bend with "H" Shaped Tip, Right; Stainless Steel....
... Perfusion Catheter is indicated for ... portion of a coronary artery ... the purpose of improving myocardial ... are also designed to provide ...
Medicine Products: